课题基金 / 基金详情

MicroRNA regulation of chronic inflammation during aging

MicroRNA regulation of chronic inflammation during aging
MicroRNA对衰老过程中慢性炎症的调节
批准号:
10817445
负责人:
Micah J Drummond
金额:
$8.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-01 至 2027-05-31

项目摘要

项目成果

Micah J Drummond的其他基金

相似基金

相关文献

中文摘要
翻译
摘要:母基金-1R01AG079477-01 慢性炎症,被称为"炎症",是许多与年龄相关的慢性病症(例如, 糖尿病、癌症、虚弱)。异常的免疫应答可能与炎症介导的代谢和 功能障碍,但存在许多机制空白。在最近受到重视的炎症调节因子中, microRNAs(miRNAs)其中一个例子是抗炎的miR-146a,我们和其他人已经研究了它。 表明缺乏这种miRNA的小鼠会死于缩短寿命的慢性炎症, 相关合并症(1 - 6)。此外,T细胞中miR-155的缺失显著延长了miR-155的寿命。 146a·1 ·小鼠,其指出T细胞表达的miR-155在这种情况下的重要作用,包括CD4 + T滤泡细胞 辅助(Tfh)细胞(3,5)。最近,我们通过研究新的 在炎症过程中,衰老T细胞中由miR-155调节的途径。通过引导单细胞RNA 测序(scRNA-Seq),我们已经确定了三个由miR-146a和miR-146b反向调节的基因程序。 miR-155在衰老T细胞中的作用,以前没有在这种情况下进行过研究。这些包括有氧糖酵解, 趋化因子产生和衰老相关分泌表型(SASP)因子。补充初步 对这些途径的初步探索所产生的数据为我们指出了一种新的、与年龄相关的 炎性cos + T细胞亚群(Taa细胞),其是GZMK "CD8"并在小鼠和人中扩增(7), 并且受miR-155调控。基于这些初步数据,我们将开展以下研究目标 为了获得对驱动炎症的T细胞依赖性机制的实质性新认识, 是由miRNAs调控的。我们还将独特地将这些分析扩展到年轻人和老年人, 将我们的发现应用到人类身上1)确定miR-155诱导的GZMK + CD8 + T细胞的功能作用 在炎症期间。2)确定miR-155的分子和代谢机制 在炎症过程中T细胞的功能。3)确定Taa和Tfh细胞及其miR-155水平是否在 老年人与慢性、低度炎症、胰岛素敏感性和肌肉萎缩的标志物相关。 实力我们预计这项工作将揭示miRNAs发挥作用的关键细胞和分子机制, 通过影响T细胞介导的、年龄依赖性慢性炎症, 炎症因此,治疗上可行的目标将出现,有可能限制年龄相关的 人类炎症性疾病在我们的社会中继续迅速流行。
英文摘要
Abstract: Parent Grant -1R01AG079477-01 Chronic inflammation, referred to as "inflammaging", is a risk factor for many age-related chronic conditions (e.g. diabetes, cancer, frailty). Aberrant immune responses may be linked to inflammatory-mediated metabolic and functional disorders but many mechanistic gaps exist. Among recently appreciated regulators of inflammaging are microRNAs (miRNAs). One example of which is the anti-inflammatory miR-146a, where we and others have shown that mice deficient in this miRNA succumb to a life-shortening chronic inflammation that involves clinically relevant comorbidities (1-6). Moreover, deletion of miR-155 in T cells significantly extends the lifespan of miR- 146a·1 • mice which points to a vital role for T cell expressed miR-155 in this context including CD4+ T follicular helper (Tfh) cells (3, 5). We have recently expanded our analyses of this critical process by investigating novel pathways in aging T cells that are regulated by miR-155 during inflammaging. By conducting single cell RNA Sequencing (scRNA-Seq) we have identified three gene programs that are counter-regulated by miR-146a and miR-155 in aged T cells that have not been previously examined in this context. These include aerobic glycolysis, chemokine production, and senescence associated secretory phenotype (SASP) factors. Additional preliminary data stemming from initial exploration of these pathways have pointed us to a novel, age-associated inflammatory cos+ T cell subset (Taa cells) that is GZMK"CD8" and that expands in both mice and humans (7), and that is regulated by miR-155. Based on these preliminary data, we will carry out the following research aims in an effort to gain substantial new insights into T cell-dependent mechanisms that drive inflammaging and that are regulated by miRNAs. We will also uniquely extend these analyses to young and older adults in efforts to translate our findings to humans. 1) Determine the functional roles of miR-155-induced GZMK+CD8+ T cells during inflammaging. 2) Determine the molecular and metabolic mechanisms underlying miR-155 functions in T cells during inflammaging. 3) Determine if Taa and Tfh cells and their miR-155 levels in older adults correlate with markers of chronic, low-grade inflammation, insulin sensitivity, and muscle strength. We anticipate that this work will unveil key cellular and molecular mechanisms by which miRNAs play pivotal roles in regulating lifespan through their influence on T cell-mediated, age-dependent chronic inflammation. As a result, therapeutically actionable targets will emerge with the potential to limit age-associated human inflammatory diseases that continue to rapidly gain in prevalence in our society.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
LOOH-induced muscle atrophy with age
  • 批准号:
    10819711
  • 项目类别:
  • 资助金额:
    $7.1万
  • 财政年份:
    2022
  • 负责人:
    Micah J Drummond
  • 依托单位:
Regulation of macrophage metabolism in aged muscle during recovery
  • 批准号:
    10622569
  • 项目类别:
  • 资助金额:
    $62.23万
  • 财政年份:
    2022
  • 负责人:
    Micah J Drummond
  • 依托单位:
LOOH-induced muscle atrophy with age
  • 批准号:
    10552003
  • 项目类别:
  • 资助金额:
    $53.73万
  • 财政年份:
    2022
  • 负责人:
    Micah J Drummond
  • 依托单位:
Regulation of macrophage metabolism in aged muscle during recovery
  • 批准号:
    10460028
  • 项目类别:
  • 资助金额:
    $62.69万
  • 财政年份:
    2022
  • 负责人:
    Micah J Drummond
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
  • 批准号:
    82505677
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.00万元
  • 批准年份:
    2025
  • 负责人:
    吕雨霏
  • 依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
  • 批准号:
    82574874
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2025
  • 负责人:
    刘天华
  • 依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位: